|
시장보고서
상품코드
2078292
외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 : 제품 종류별, 용도별, 최종사용자별, 지역별Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type, By Application, By End User, and By Region |
||||||
외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 규모는 2026년에 66억 790만 달러로 추정되며, 2033년까지 113억 2,470만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 8.0%로 성장할 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 66억 790만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 8.00% | 예측 금액(2033년) | 113억 2,470만 달러 |
외과용 지혈제는 출혈을 제어하기 위해 사용되는 수술기구입니다. 수술 초기 단계에서는 결찰을 기다리는 혈관을 막기 위해 첫 번째 절개 부위에 지혈 집게를 배치해 두는 것이 일반적입니다. 내부 조직 실란트는 조직을 밀폐하여 내출혈을 억제하는 데 사용되는 흡수성 재료입니다. 따라서, 이러한 조치들은 수술 부위에서 체액이 새는 것을 방지할 수 있습니다. 이것들은 조직끼리 접착하여 치유를 돕기 위해 사용되는 외과용 접착제나 접착제입니다. 한편, 유착 방지제는 조직이나 장기가 치유되는 과정에서 그 사이에 내부 유착이 발생하는 것을 방지하기 위해 사용되는 의료용 임플란트입니다. 동물 유래 막, 금박, 광물유, 고무 시트, 테플론 등의 약제나 재료가 유착 형성의 위험을 줄이기 위해 사용됩니다. 이 세 가지 수술용 재료는 수술 중 및 수술 후 출혈을 제어하는 데 사용됩니다.
시장 역학
사고 및 화상 발생 건수의 증가, 심혈관질환 유병률의 상승, 그리고 규제 당국의 신제품 승인이 전 세계 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장의 성장 요인으로 작용하고 있습니다. 예를 들어, 2021년 2월 23일, 미국에 본사를 둔 의료기기 제조업체인 EndoClot Plus Inc.는 위장관 출혈을 신속하고 확실하게 지혈하는 혁신적인 제품인 'EndoClot Polysaccharide Hemostatic System(EndoClot PHS)'에 대해 미국 식품의약국(FDA)의 승인을 획득했습니다. EndoClot PHS는 유연한 내시경을 통해 출혈 부위에 직접 적용되는, 전분 기반의 분말 지혈제를 포함하는 일회용 의료기기입니다. 흡수성 개질 폴리머(AMP) 분말은 혈액을 신속하게 응집시켜 정상적인 생리적 응고 과정을 촉진합니다. AMP 분말이 소화관 내의 혈액이나 체액과 접촉하면 젤 형태의 매트릭스가 형성되어, 기계적 장벽 역할을 하여 출혈을 더욱 억제합니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 : 제품 종류별(2021-2033년)
제5장 세계의 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 : 용도별(2021-2033년)
제6장 세계의 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 : 최종사용자별(2021-2033년)
제7장 세계의 외과용 지혈제, 내부 조직 실란트, 유착 방지제 시장 : 종류별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.15Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is estimated to be valued at USD 6,607.9 Mn in 2026 and is expected to reach USD 11,324.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6,607.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 11,324.7 Mn |
A surgical hemostat is a surgical tool used to control bleeding. It is common in the initial phases of surgery for the initial incision to be lined with hemostats that close blood vessels awaiting ligation. Internal tissue sealants are absorbable materials used to control internal bleeding by sealing the tissue. Thus, they can prevent leaks of fluid from the surgical incision. These are surgical glues and adhesives used for attaching tissue to one other to help in repair. While, adhesion barriers are the medical implants used to prevent the formation of internal adherence between tissues, and organs when they are healing. Drugs and materials such as animal membranes, gold foil, mineral oil, sheets of rubber, and Teflon are used to reduce the risk of adhesion formation. These three surgical materials are used to control bleeding during and after surgical procedures.
Market Dynamics
Increasing incidences of accidents and burns, increasing prevalence of cardiovascular diseases, and approvals of new products by regulatory authorities are attributed to the growth of the global surgical hemostats, internal tissue sealants, and adhesion barriers market. For instance, on February 23, 2021, EndoClot Plus Inc., a U.S.-based medical device company, received U.S. Food and Drug Administration approval (FDA) for its product EndoClot Polysaccharide Hemostatic System (EndoClot PHS), an innovative product that helps to stop gastrointestinal bleeding rapidly and reliably. EndoClot PHS is a single-use device including a starch-based powder hemostat that is applied directly to the bleeding site through a flexible endoscope. The Absorbable Modified Polymer (AMP) powder can quickly concentrate the blood to accelerate the normal physiological clotting process. A gelled matrix forms when the AMP powder contacts blood or fluid in the GI tract to provide a mechanical barrier to further control bleeding.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global surgical hemostats, internal tissue sealants, and adhesion barriers market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global surgical hemostats, internal tissue sealants, and adhesion barriers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global surgical hemostats, internal tissue sealants, and adhesion barriers market.
Detailed Segmentation:
- Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Hemostats
- Thrombin Based
- Combination Hemostats
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Internal Tissue Sealants
- Fibrin Based
- Collagen Based
- Protein Based
- Synthetic Polymer Based
- Adhesion Barriers
- Film Based
- Gel Based
- Solution Based
- Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Surgical Applications
- Cardiovascular Surgeries
- Neurological Surgeries
- Orthopedic Surgeries
- Urological & Gynecological Surgeries
- General Surgeries
- Reconstructive and Plastic Surgeries
- Others
- Trauma Cases
- Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Ethicon (Johnson & Johnson)
- Baxter International Inc.
- Integra LifeSciences Holdings Corporation
- Pfizer Inc.
- Tissuemed Ltd.
- Sanofi
- Braun Melsungen AG
- R. Bard, Inc.
- CryoLife, Inc.
- Cohera Medical, Inc.
- CSL Behring
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End user
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Product Type, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hemostat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
- Thrombin Based
- Combination Hemostats
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Internal Tissue Sealants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
- Fibrin Based
- Collagen Based
- Protein Based
- Synthetic Polymer Based
- Adhesion Barrier
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
- Film Based
- Gel Based
- Solution Based
5. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Application, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Surgical Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment trends
- Cardiovascular Surgeries
- Neurological Surgeries
- Orthopedic Surgeries
- Urological & Gynecological Surgeries
- General Surgeries
- Reconstructive and Plastic Surgeries
- Others
- Trauma Cases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By End user, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Region, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Ethicon (Johnson & Johnson)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter International Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Integra LifeSciences Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tissuemed Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- R. Bard, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CryoLife, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cohera Medical, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CSL Behring
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
